Linagliptin also exerted ameliorative effects in MPTP-induced PD mice by suppressing TLR4, NF-κB, and TNF-α, upregulating GLP-1 and TH, and improving behavioral changes [35]. This evidence concerns the gene TLR4 and Parkinson disease.